Dr. Erin Mulvey is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine. She competed her undergraduate education at Boston University where she earned a degree in Biochemistry and Molecular Biology. She received her medical degree from New York Medical College. Dr. Mulvey completed both her Residency in Internal Medicine and her Fellowship in Hematology/Oncology at NewYork-Presbyterian Hospital and Weill Cornell Medical College. Dr. Mulvey has also completed a Master's Degree in Clinical Investigation and Translational Research at the Weill Cornell School of Graduate Sciences.

Dr. Mulvey is a member of the Weill Cornell Lymphoma Program where she specializes in treating patients with lymphoma and chronic lymphocytic leukemia (CLL) and is an active investigator in several clinical trials. Her research is centered on B cell lymphomas, including indolent lymphomas such as follicular lymphoma as well as aggressive forms such as diffuse large B-cell lymphoma. Dr. Mulvey is focused on the study and manipulation of the interaction between the body’s own immune system and cancerous cells. She also has a special interest in utilizing patient reported outcomes in clinical trials, and has received honors from the Lymphoma Research Foundation (LRF) and the NIH.